BioPharmX Corporation, a specialty pharmaceutical company, announced that research being presented at the 2016 Winter Clinical Dermatology Conference shows its

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

New User Registration
 
 
 
 
 
 
 
 
*Required field